FBRX compared with NERV: revenue, margins and what each company keeps, and the suppliers and customers both name

FBRXForte Biosciences, Inc.

Mkt capRevenueRevenue

NERVMinerva Neurosciences, Inc.

Mkt capRevenueRevenue

Compare

FBRXForte Biosciences, Inc.

NERVMinerva Neurosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only FBRX 0

None

Shared 0

No disclosed counterparties: FBRX.

Only NERV 7

RPRXRoyalty Pharma plc ("Royalty Pharma")customer

—Catalentunlistedsupplier

—Catalent Germany Schorndorf GmbHunlistedsupplier

—Dr. Inderjit Kaulunlistedsupplier

3 more · NERV chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

FBRXForte Biosciences, Inc.

77.01▲+0.05%

Mkt cap$1.6B

NERVMinerva Neurosciences, Inc.

2.33▼−0.81%

Regular sessionNov 3 '26

Mkt cap$112.0M

Compare

Regular sessionNov 3 '26

FBRXForte Biosciences, Inc.

NERVMinerva Neurosciences, Inc.

77.01▲+0.05%

Price

2.33▼−0.81%

$1.6B

Mkt cap

$112.0M

FBRX77.01▲+0.05%vsNERV2.33▼−0.81%Regular sessionNov 3 '26